Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Author Correction: Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis.

Dufton NP, Peghaire CR, Osuna-Almagro L, Raimondi C, Kalna V, Chauhan A, Webb G, Yang Y, Birdsey GM, Lalor P, Mason JC, Adams DH, Randi AM.

Nat Commun. 2020 Mar 5;11(1):1301. doi: 10.1038/s41467-020-15151-w.

2.

Detecting the disappearance of RAS-mutant clones in the plasma of patients with RAS-mutant mCRC to select patient candidates for anti-EGFR treatment and to monitor resistance to treatment.

Raimondi C, Loreni F, Nicolazzo C, Belardinilli F, Wilson A, Gradilone A, Giannini G, Gazzaniga P, Cortesi E.

Ann Oncol. 2019 Jul;30 Suppl 4:iv38. doi: 10.1093/annonc/mdz155.140. Epub 2019 Dec 4. No abstract available.

PMID:
32085139
3.

The transcription factor ERG regulates a low shear stress-induced anti-thrombotic pathway in the microvasculature.

Peghaire C, Dufton NP, Lang M, Salles-Crawley II, Ahnström J, Kalna V, Raimondi C, Pericleous C, Inuabasi L, Kiseleva R, Muzykantov VR, Mason JC, Birdsey GM, Randi AM.

Nat Commun. 2019 Nov 1;10(1):5014. doi: 10.1038/s41467-019-12897-w.

4.

EpCAMlow Circulating Tumor Cells: Gold in the Waste.

Nicolazzo C, Gradilone A, Loreni F, Raimondi C, Gazzaniga P.

Dis Markers. 2019 Sep 17;2019:1718920. doi: 10.1155/2019/1718920. eCollection 2019. Review.

5.

Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer.

Nicolazzo C, Raimondi C, Gradilone A, Emiliani A, Zeuner A, Francescangeli F, Belardinilli F, Seminara P, Loreni F, Magri V, Tomao S, Gazzaniga P.

Cancers (Basel). 2019 Jul 24;11(8). pii: E1042. doi: 10.3390/cancers11081042.

6.

Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial.

Nicolazzo C, Busetto GM, Gradilone A, Sperduti I, Del Giudice F, Loreni F, Cortesi E, de Berardinis E, Gazzaniga P, Raimondi C.

Oncologist. 2019 May;24(5):612-616. doi: 10.1634/theoncologist.2018-0784. Epub 2019 Apr 3.

7.

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.

Cristofanilli M, Pierga JY, Reuben J, Rademaker A, Davis AA, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Giuliano M, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Cabel L, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Generali D, Cappelletti MR, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Darrigues L, Reis-Filho JS, Gerratana L, Michiels S, Bidard FC, Pantel K.

Crit Rev Oncol Hematol. 2019 Feb;134:39-45. doi: 10.1016/j.critrevonc.2018.12.004. Epub 2018 Dec 19. Review.

PMID:
30771872
8.

Neuropilin-1 Controls Endothelial Homeostasis by Regulating Mitochondrial Function and Iron-Dependent Oxidative Stress.

Issitt T, Bosseboeuf E, De Winter N, Dufton N, Gestri G, Senatore V, Chikh A, Randi AM, Raimondi C.

iScience. 2019 Jan 25;11:205-223. doi: 10.1016/j.isci.2018.12.005. Epub 2018 Dec 11.

9.

Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer.

Raimondi C, Nicolazzo C, Belardinilli F, Loreni F, Gradilone A, Mahdavian Y, Gelibter A, Giannini G, Cortesi E, Gazzaniga P.

Cancers (Basel). 2019 Jan 4;11(1). pii: E42. doi: 10.3390/cancers11010042.

10.

Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion.

Nicolazzo C, Gradilone A, Carpino G, Gazzaniga P, Raimondi C.

Methods Mol Biol. 2019;1884:247-258. doi: 10.1007/978-1-4939-8885-3_17.

PMID:
30465208
11.

Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma.

Nicolazzo C, Colangelo L, Corsi A, Carpino G, Gradilone A, Sonato C, Raimondi C, Gaudio E, Gazzaniga P, Gianni W.

Anal Cell Pathol (Amst). 2018 Mar 7;2018:9718585. doi: 10.1155/2018/9718585. eCollection 2018.

12.

Molecular signature of the imprintosome complex at the mating-type locus in fission yeast.

Raimondi C, Jagla B, Proux C, Waxin H, Gangloff S, Arcangioli B.

Microb Cell. 2018 Jan 16;5(4):169-183. doi: 10.15698/mic2018.04.623.

13.

Epidemiologic Study and Genotyping of BK Virus in Renal Transplant Recipients.

Cobos M, Aquilia L, Garay E, Ochiuzzi S, Alvarez S, Flores D, Raimondi C.

Transplant Proc. 2018 Mar;50(2):458-460. doi: 10.1016/j.transproceed.2017.12.044.

PMID:
29579827
14.

Natural history and genotype-phenotype correlations in 72 individuals with SATB2-associated syndrome.

Zarate YA, Smith-Hicks CL, Greene C, Abbott MA, Siu VM, Calhoun ARUL, Pandya A, Li C, Sellars EA, Kaylor J, Bosanko K, Kalsner L, Basinger A, Slavotinek AM, Perry H, Saenz M, Szybowska M, Wilson LC, Kumar A, Brain C, Balasubramanian M, Dubbs H, Ortiz-Gonzalez XR, Zackai E, Stein Q, Powell CM, Schrier Vergano S, Britt A, Sun A, Smith W, Bebin EM, Picker J, Kirby A, Pinz H, Bombei H, Mahida S, Cohen JS, Fatemi A, Vernon HJ, McClellan R, Fleming LR, Knyszek B, Steinraths M, Velasco Gonzalez C, Beck AE, Golden-Grant KL, Egense A, Parikh A, Raimondi C, Angle B, Allen W, Schott S, Algrabli A, Robin NH, Ray JW, Everman DB, Gambello MJ, Chung WK.

Am J Med Genet A. 2018 Apr;176(4):925-935. doi: 10.1002/ajmg.a.38630. Epub 2018 Feb 13.

PMID:
29436146
15.

PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?

Raimondi C, Carpino G, Nicolazzo C, Gradilone A, Gianni W, Gelibter A, Gaudio E, Cortesi E, Gazzaniga P.

Oncoimmunology. 2017 Apr 20;6(12):e1315488. doi: 10.1080/2162402X.2017.1315488. eCollection 2017.

16.

Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease.

Cuna V, Menghi V, Comai G, Cappuccilli M, Cianciolo G, Raimondi C, Grammatico F, Donati G, Baraldi O, Capelli I, LA Manna G.

In Vivo. 2017 Nov-Dec;31(6):1203-1208.

17.

Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis.

Dufton NP, Peghaire CR, Osuna-Almagro L, Raimondi C, Kalna V, Chauhan A, Webb G, Yang Y, Birdsey GM, Lalor P, Mason JC, Adams DH, Randi AM.

Nat Commun. 2017 Oct 12;8(1):895. doi: 10.1038/s41467-017-01169-0. Erratum in: Nat Commun. 2020 Mar 5;11(1):1301.

18.
19.

EpCAM-expressing circulating tumor cells in colorectal cancer.

Nicolazzo C, Raimondi C, Francescangeli F, Ceccarelli S, Trenta P, Magri V, Marchese C, Zeuner A, Gradilone A, Gazzaniga P.

Int J Biol Markers. 2017 Oct 31;32(4):e415-e420. doi: 10.5301/ijbm.5000284.

PMID:
28604994
20.

The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC).

Nicolazzo C, Busetto GM, Del Giudice F, Sperduti I, Giannarelli D, Gradilone A, Gazzaniga P, de Berardinis E, Raimondi C.

J Cancer Res Clin Oncol. 2017 Oct;143(10):1971-1976. doi: 10.1007/s00432-017-2449-8. Epub 2017 May 29.

PMID:
28555356
21.

VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.

Fantin A, Lampropoulou A, Senatore V, Brash JT, Prahst C, Lange CA, Liyanage SE, Raimondi C, Bainbridge JW, Augustin HG, Ruhrberg C.

J Exp Med. 2017 Apr 3;214(4):1049-1064. doi: 10.1084/jem.20160311. Epub 2017 Mar 13.

22.

Correction: A novel regulatory mechanism links PLCγ1 to PDK1.

Raimondi C, Chikh A, Wheeler AP, Maffucci T, Falasca M.

J Cell Sci. 2017 Mar 1;130(5):1016. doi: 10.1242/jcs.201491. No abstract available.

23.

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab.

Nicolazzo C, Raimondi C, Mancini M, Caponnetto S, Gradilone A, Gandini O, Mastromartino M, Del Bene G, Prete A, Longo F, Cortesi E, Gazzaniga P.

Sci Rep. 2016 Aug 24;6:31726. doi: 10.1038/srep31726.

24.

Bond strength of resin cements to dentin using universal bonding agents.

Raimondi CJ, Jessup JP, Ashcraft-Olmscheid D, Vandewalle KS.

Am J Dent. 2016 Jun;29(3):175-9.

PMID:
27505996
25.

A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion.

Raimondi C, Calleja V, Ferro R, Fantin A, Riley AM, Potter BV, Brennan CH, Maffucci T, Larijani B, Falasca M.

Sci Rep. 2016 May 20;6:26142. doi: 10.1038/srep26142.

26.

NRP1 function and targeting in neurovascular development and eye disease.

Raimondi C, Brash JT, Fantin A, Ruhrberg C.

Prog Retin Eye Res. 2016 May;52:64-83. doi: 10.1016/j.preteyeres.2016.02.003. Epub 2016 Feb 27. Review.

27.

Development of an Innovative Treatment Paradigm for Intimate Partner Violence Victims With Depression and Pain Using Community-Based Participatory Research.

Poleshuck E, Mazzotta C, Resch K, Rogachefsky A, Bellenger K, Raimondi C, Thompson Stone J, Cerulli C.

J Interpers Violence. 2018 Sep;33(17):2704-2724. doi: 10.1177/0886260516628810. Epub 2016 Feb 12.

28.

Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells.

Nicolazzo C, Massimi I, Lotti LV, Vespa S, Raimondi C, Pulcinelli FM, Gradilone A, Gazzaniga P.

Chin J Cancer Res. 2015 Oct;27(5):491-6. doi: 10.3978/j.issn.1000-9604.2015.04.09.

29.

Circulating tumor cells isolation: the "post-EpCAM era".

Raimondi C, Nicolazzo C, Gradilone A.

Chin J Cancer Res. 2015 Oct;27(5):461-70. doi: 10.3978/j.issn.1000-9604.2015.06.02. Review.

30.

Deaf Victims' Experiences With Intimate Partner Violence: The Need for Integration and Innovation.

Mastrocinque JM, Thew D, Cerulli C, Raimondi C, Pollard RQ Jr, Chin NP.

J Interpers Violence. 2017 Dec;32(24):3753-3777. doi: 10.1177/0886260515602896. Epub 2015 Sep 13.

PMID:
26371087
31.

NRP1 Regulates CDC42 Activation to Promote Filopodia Formation in Endothelial Tip Cells.

Fantin A, Lampropoulou A, Gestri G, Raimondi C, Senatore V, Zachary I, Ruhrberg C.

Cell Rep. 2015 Jun 16;11(10):1577-90. doi: 10.1016/j.celrep.2015.05.018. Epub 2015 Jun 4. Erratum in: Cell Rep. 2015 Dec 1;13(9):2037.

32.

The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells.

Gazzaniga P, Raimondi C, Nicolazzo C, Carletti R, di Gioia C, Gradilone A, Cortesi E.

Expert Rev Mol Diagn. 2015;15(7):925-32. doi: 10.1586/14737159.2015.1045491. Epub 2015 May 9. Review.

PMID:
25959553
33.

Facilitating Intimate Partner Violence Education among Pharmacy Students: What Do Future Pharmacists Want to Know?

Cerulli C, Nichols-Hadeed C, Raimondi C, Stone JT, Cerulli J.

Curr Pharm Teach Learn. 2015 May-Jun;7(3):283-291.

34.

Imatinib may be ABL to improve anti-angiogenic therapy.

Raimondi C, Fantin A, Ruhrberg C.

Mol Cell Oncol. 2015 Feb 24;2(1):e968034. doi: 10.4161/23723548.2014.968034. eCollection 2015 Jan-Mar.

35.

Neuropilin-1 enforces extracellular matrix signalling via ABL1 to promote angiogenesis.

Raimondi C.

Biochem Soc Trans. 2014 Oct;42(5):1429-34. doi: 10.1042/BST20140141. Review.

PMID:
25233427
36.

Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.

Raimondi C, Fantin A, Lampropoulou A, Denti L, Chikh A, Ruhrberg C.

J Exp Med. 2014 Jun 2;211(6):1167-83. doi: 10.1084/jem.20132330. Epub 2014 May 26.

37.

Clinical utility of circulating tumor cell counting through CellSearch(®): the dilemma of a concept suspended in Limbo.

Raimondi C, Gradilone A, Naso G, Cortesi E, Gazzaniga P.

Onco Targets Ther. 2014 Apr 17;7:619-25. doi: 10.2147/OTT.S46200. eCollection 2014. Review.

38.

iASPP is a novel autophagy inhibitor in keratinocytes.

Chikh A, Sanzà P, Raimondi C, Akinduro O, Warnes G, Chiorino G, Byrne C, Harwood CA, Bergamaschi D.

J Cell Sci. 2014 Jul 15;127(Pt 14):3079-93. doi: 10.1242/jcs.144816. Epub 2014 Apr 28.

39.

Circulating tumor cells in early bladder cancer: insight into micrometastatic disease.

Raimondi C, Gradilone A, Gazzaniga P.

Expert Rev Mol Diagn. 2014 May;14(4):407-9. doi: 10.1586/14737159.2014.908119. Epub 2014 Apr 10.

PMID:
24717055
40.

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Lebofsky R, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Johannes H, Reis-Filho JS, Pantel K, Pierga JY, Michiels S.

Lancet Oncol. 2014 Apr;15(4):406-14. doi: 10.1016/S1470-2045(14)70069-5. Epub 2014 Mar 11.

PMID:
24636208
41.

Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer.

Gazzaniga P, de Berardinis E, Raimondi C, Gradilone A, Busetto GM, De Falco E, Nicolazzo C, Giovannone R, Gentile V, Cortesi E, Pantel K.

Int J Cancer. 2014 Oct 15;135(8):1978-82. doi: 10.1002/ijc.28830. Epub 2014 Mar 13.

42.

Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer.

Raimondi C, Nicolazzo C, Gradilone A, Giannini G, De Falco E, Chimenti I, Varriale E, Hauch S, Plappert L, Cortesi E, Gazzaniga P.

Cancer Biol Ther. 2014 May;15(5):496-503. doi: 10.4161/cbt.28020. Epub 2014 Feb 12.

43.

Piloting a psycho-social intervention for incarcerated women with trauma histories: lessons learned and future recommendations.

Liebman RE, Burnette ML, Raimondi C, Nichols-Hadeed C, Merle P, Cerulli C.

Int J Offender Ther Comp Criminol. 2014 Aug;58(8):894-913. doi: 10.1177/0306624X13491073. Epub 2013 Jun 26.

PMID:
23804649
44.

Controversies in circulating tumor cell count during therapy.

Raimondi C, Gradilone A, Gazzaniga P.

Expert Rev Mol Diagn. 2013 Jun;13(5):499-507. doi: 10.1586/erm.13.33. Review.

PMID:
23782256
45.

Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?

Gazzaniga P, Raimondi C, Gradilone A, Biondi Zoccai G, Nicolazzo C, Gandini O, Longo F, Tomao S, Lo Russo G, Seminara P, Vincenzi B, Chimenti I, Cristofanilli M, Frati L, Cortesi E.

J Cancer Res Clin Oncol. 2013 Aug;139(8):1411-6. doi: 10.1007/s00432-013-1450-0. Epub 2013 Jun 5.

PMID:
23736274
46.

Evaluation of histological damage of solid organs after donor preconditioning with thymoglobulin in an experimental rat model.

Cicora F, Stringa P, Guerrieri D, Vásquez D, Toniolo F, Roberti J, Raimondi C.

Transpl Immunol. 2013 Jun;28(4):203-5. doi: 10.1016/j.trim.2013.04.002. Epub 2013 Apr 15.

PMID:
23597700
47.

Circulating tumor cells in high-risk nonmetastatic colorectal cancer.

Gazzaniga P, Gianni W, Raimondi C, Gradilone A, Lo Russo G, Longo F, Gandini O, Tomao S, Frati L.

Tumour Biol. 2013 Oct;34(5):2507-9. doi: 10.1007/s13277-013-0752-9. Epub 2013 Mar 29.

PMID:
23539436
48.

Neuropilin signalling in vessels, neurons and tumours.

Raimondi C, Ruhrberg C.

Semin Cell Dev Biol. 2013 Mar;24(3):172-8. doi: 10.1016/j.semcdb.2013.01.001. Epub 2013 Jan 11. Review.

PMID:
23319134
49.

Anti-neutrophil cytoplasmic autoantibody-associated vasculitis in the very elderly: a 90-year-old iron lady.

Donati G, Cianciolo G, La Manna G, Fusconi M, Raimondi C, Grandinetti V, Kwedi CK, Righi S, Ferri S, Stefoni S.

Geriatr Gerontol Int. 2013 Jan;13(1):230-2. doi: 10.1111/j.1447-0594.2012.00924.x. No abstract available.

PMID:
23286565
50.

"What Fresh Hell Is This?" Victims of Intimate Partner Violence Describe Their Experiences of Abuse, Pain, and Depression.

Cerulli C, Poleshuck E, Raimondi C, Veale S, Chin N.

J Fam Violence. 2012 Nov;27(8):773-781.

Supplemental Content

Loading ...
Support Center